Effectiveness of Levetiracetam in the Treatment of Lumbar Radiculopathy: An Open‐Label Prospective Cohort Study

Wiley - Tập 1 Số 4 - Trang 335-339 - 2009
Maged S. Maged S., David Greg David Greg, John W. John W., Steven Steven, David X. David X.

Tóm tắt

ObjectiveThe purpose of this open‐label study was to assess the effectiveness and tolerability of levetiracetam (LEV) in the treatment of patients with lower lumbar radiculopathy diagnosed by clinical presentation, physical examination, and electrodiagnostics.DesignOpen‐label, forced titration, prospective cohort intent‐to‐treat analysis.SettingMajor teaching hospital.PatientsParticipants were recruited from the university pain clinic and through referrals from the community. Subjects were eligible to participate if they (1) were older than 18 years, (2) had leg pain greater than back pain, (3) had been symptomatic for 6 months and <5 years, (3) had a baseline visual analog scale of at least 6 on the 0‐10 scale, (4) had undergone lumbar spine magnetic resonance imaging within the last 12 months that showed no surgically correctable etiology for their radicular symptoms, and (5) had undergone electrodiagnostics that was positive for lumbar radiculopathy (L4, L5, or S1 nerve roots). Twenty‐six patients were enrolled, and 24 (92.3%) completed the study.InterventionsPatients initially received LEV 500 mg twice a day for 2 weeks. Dosages were then increased to 750 mg twice day for 2 weeks, and then to 1500 mg twice a day for the remainder of the study. Patients were observed for 8 weeks after reaching the maximum dose.Main Outcome MeasurementsTreatment effectiveness was assessed with the use of biweekly brief pain inventory and patient global assessment scales. Frequency and severity of adverse events were recorded.ResultsThe mean biweekly worst and average pain scores decreased from 7.17 and 6.27 at baseline to 4.2 and 3.9, respectively, at week 12 (P ≤ .001). Improvements were reported in general activity, ability to walk, mood, and relationship with people. Side effects consisted of sedation/drowsiness (46%), gastrointestinal upset (23%), headache (19%), blurred vision (15%), weakness/fatigue (11%), and dyscoordination (11%).ConclusionsThis study showed that LEV might be a well‐tolerated and effective treatment for lumbar radiculopathy. A large randomized placebo‐controlled trial is recommended and comparative studies with alternative agents should be sought.

Tài liệu tham khảo

10.1016/S0140-6736(99)01307-0 10.1097/00002508-200006001-00012 10.3810/hp.1998.10.114 10.1054/jpai.2000.9435 10.1001/archneur.60.11.1524 10.1097/00002508-200211000-00001 10.1212/WNL.59.5_suppl_2.S14 10.1097/00007611-199907000-00001 10.1136/bmj.311.7012.1047 10.1016/S0304-3959(97)00049-3 10.1016/S0163-7258(99)00052-2 10.1006/phrs.2000.0689 Klitgaard H., 2001, Levetiracetam: The preclinical profile of a new class of antiepileptic drugs?, Epilepsia, 42, 13, 10.1046/j.1528-1157.2001.00003.x 10.1111/j.1528-1157.2000.tb00323.x 10.1111/j.1528-1167.2001.00007.x 10.1111/j.1528-1167.2001.00008.x 10.1002/j.1552-4604.2000.tb05984.x UCB Pharma Inc.Keppra® (levetiracetam) Tablets and Oral Solution Prescribing Informationhttp://keppra.com Accessed May 1 2004 Jenson M., 2001, Gabapentin and levetiracetam for the treatment of neuropathic pain: A prospective open label trial, Am J Pain Manage, 11, 125 Rowbotham M., 2003, Prospective pilot study of Levetiracetam for post‐herpetic neuralgia pain and allodynia, Neurology, 4, 71 Dunteman E., 2003, Levetiracetam adjunctive analgesia in neoplastic plexopathies, J Pain, 4, 87 Cochran J., 2003, Levetiracetam in cervical and lumbar radiculopathy: A pilot study, J Pain, 4, 89 10.1097/00002508-200401000-00007 Krusz J.C., 2002, Levetiracetam for chronic neuropathic pain treatment, J Pain, 3, 40 Paterson S., 2003, Levetiracetam is effective in the treatment of chronic pain: a prospective open label case series, J Pain, 4, 89 Rizzo M., 2003, Adjunctive levetiracetam therapy for myelopathic pain and paresthesias in MS, J Pain, 4, 79 Pritchard D., 2003, Levetiracetam (Keppra): A community pain clinic experience with large numbers of patients with different types of pain, J Pain, 4, 90 Empting L., 2003, Levetiracetam in the treatment of traumatically induced sympathetic independent neuropathic pain, and post‐operative radiculopathy, J Pain, 4, 84 Cochran J., 2003, Levetiracetam (Keppra®) in neuropathic pain: A pilot study, J Pain, 4, 90 10.1097/00002060-200011000-00002 10.1016/0304-3959(83)90143-4 10.1016/j.jpain.2004.09.001 10.1111/j.1742-1241.2007.01589.x 10.1054/jpai.2000.9435 10.1097/00002826-199510000-00002 10.1111/j.1499-1654.2000.001499.x 10.1016/S0304-3959(99)00154-2
Thông tin
Thông tin xuất bản

Wiley

Tập 1 Số 4

335-339

Thông tin tác giả